Trastuzumab biosimilar in early breast cancer setting: Will there be direct patient benefits?
Access Status
Fulltext not available
Authors
Chan, Arlene
Date
2017Type
Journal Article
Metadata
Show full item recordCitation
Chan, A. 2017. Trastuzumab biosimilar in early breast cancer setting: Will there be direct patient benefits?. Chinese Clinical Oncology. 6 (5).
Source Title
Chinese Clinical Oncology
ISSN
School
Curtin Medical School